FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2930056687> ?p ?o ?g. }

• W2930056687 endingPage "2395" @default.
• W2930056687 startingPage "2383" @default.
• W2930056687 abstract "The inflammatory basis of diabetes mellitus directed the researchers' attention to the immune system for better management and prevention of complications. Metoclopramide (MCA; the only US Food and Drug Administration-approved for gastroparesis) has the ability to restore immune function through increasing prolactin secretion. This study aimed to test the effect of BSA/MCA nanoparticles (NPs) on modulating immune response.BSA/MCA NPs were fabricated by desolvation and evaluated in vitro via measuring loading efficiency, particle size, and surface charge. The selected formula was further evaluated via differential scanning calorimetry and release behavior. Then, NPs were injected into rats (25 mg MCA/kg/week) for 3 weeks to be evaluated histopathologically and immunologically via measuring proinflammatory cytokines, such as IL1β, IL6, and TNFα, in addition to measuring regulatory T-cell frequency.MCA was successfully loaded on BSA, achieving high encapsulation efficiency reaching 63±2%, particles size of 120-130 nm with good polydispersity, and a negative surface charge indicating that entire positively charged drug was encapsulated inside NPs. Differential scanning calorimetry thermography of selected NPs showed an obvious interaction between components and cross-linking of BSA molecules using glutaraldehyde, resulting in sustained release of MCA (around 50% within 3 days). MCA NPs significantly restored the immune response via decreasing proinflammatory cytokines and increasing regulatory T-cell frequency when compared to control and free MCA (drug not loaded in NPs)-treated groups. Histopathological examination of this MCA NPs-treated group did not show the characteristic lesions of diabetes, and apoptosis nearly disappeared.BSA/MCA NPs could be considered a new modality for treatment of gastro-paresis, in addition to management of diabetes itself and preventing its complications via an MCA-immunomodulatory effect." @default.
• W2930056687 created "2019-04-11" @default.
• W2930056687 creator A5012947617 @default.
• W2930056687 creator A5020291342 @default.
• W2930056687 creator A5044113842 @default.
• W2930056687 creator A5046129840 @default.
• W2930056687 creator A5066619473 @default.
• W2930056687 creator A5087999270 @default.
• W2930056687 date "2019-04-01" @default.
• W2930056687 modified "2023-10-18" @default.
• W2930056687 title "<p>Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines</p>" @default.
• W2930056687 cites W1551403545 @default.
• W2930056687 cites W1561356536 @default.
• W2930056687 cites W1589953995 @default.
• W2930056687 cites W1833815221 @default.
• W2930056687 cites W1977824936 @default.
• W2930056687 cites W1979509893 @default.
• W2930056687 cites W1982628018 @default.
• W2930056687 cites W1983269317 @default.
• W2930056687 cites W1985882893 @default.
• W2930056687 cites W1986950852 @default.
• W2930056687 cites W1989927946 @default.
• W2930056687 cites W1997390350 @default.
• W2930056687 cites W2003658953 @default.
• W2930056687 cites W2024020026 @default.
• W2930056687 cites W2031882974 @default.
• W2930056687 cites W2034921827 @default.
• W2930056687 cites W2041998484 @default.
• W2930056687 cites W2043428857 @default.
• W2930056687 cites W2048211245 @default.
• W2930056687 cites W2055844905 @default.
• W2930056687 cites W2057811513 @default.
• W2930056687 cites W2062834088 @default.
• W2930056687 cites W2063288604 @default.
• W2930056687 cites W2064082832 @default.
• W2930056687 cites W2067700751 @default.
• W2930056687 cites W2068804610 @default.
• W2930056687 cites W2085298630 @default.
• W2930056687 cites W2085918020 @default.
• W2930056687 cites W2090719817 @default.
• W2930056687 cites W2093590356 @default.
• W2930056687 cites W2094291556 @default.
• W2930056687 cites W2110649443 @default.
• W2930056687 cites W2112620654 @default.
• W2930056687 cites W2122659224 @default.
• W2930056687 cites W2126916701 @default.
• W2930056687 cites W2129316761 @default.
• W2930056687 cites W2134929591 @default.
• W2930056687 cites W2144475530 @default.
• W2930056687 cites W2145179176 @default.
• W2930056687 cites W2155177711 @default.
• W2930056687 cites W2157120247 @default.
• W2930056687 cites W2159601803 @default.
• W2930056687 cites W2271979548 @default.
• W2930056687 cites W2274008531 @default.
• W2930056687 cites W2295443024 @default.
• W2930056687 cites W2325925001 @default.
• W2930056687 cites W2360439189 @default.
• W2930056687 cites W2430048569 @default.
• W2930056687 cites W2480909796 @default.
• W2930056687 cites W2513979889 @default.
• W2930056687 cites W2761612869 @default.
• W2930056687 cites W2804688828 @default.
• W2930056687 cites W2883586845 @default.
• W2930056687 cites W297750265 @default.
• W2930056687 cites W3004347905 @default.
• W2930056687 cites W3015104528 @default.
• W2930056687 cites W3016148918 @default.
• W2930056687 cites W31842883 @default.
• W2930056687 cites W4240175730 @default.
• W2930056687 cites W749370348 @default.
• W2930056687 doi "https://doi.org/10.2147/ijn.s196842" @default.
• W2930056687 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6452795" @default.
• W2930056687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31040663" @default.
• W2930056687 hasPublicationYear "2019" @default.
• W2930056687 type Work @default.
• W2930056687 sameAs 2930056687 @default.
• W2930056687 citedByCount "16" @default.
• W2930056687 countsByYear W29300566872019 @default.
• W2930056687 countsByYear W29300566872020 @default.
• W2930056687 countsByYear W29300566872021 @default.
• W2930056687 countsByYear W29300566872022 @default.
• W2930056687 countsByYear W29300566872023 @default.
• W2930056687 crossrefType "journal-article" @default.
• W2930056687 hasAuthorship W2930056687A5012947617 @default.
• W2930056687 hasAuthorship W2930056687A5020291342 @default.
• W2930056687 hasAuthorship W2930056687A5044113842 @default.
• W2930056687 hasAuthorship W2930056687A5046129840 @default.
• W2930056687 hasAuthorship W2930056687A5066619473 @default.
• W2930056687 hasAuthorship W2930056687A5087999270 @default.
• W2930056687 hasBestOaLocation W29300566871 @default.
• W2930056687 hasConcept C121332964 @default.
• W2930056687 hasConcept C164027704 @default.
• W2930056687 hasConcept C185592680 @default.
• W2930056687 hasConcept C192562407 @default.
• W2930056687 hasConcept C203014093 @default.
• W2930056687 hasConcept C2776914184 @default.
• W2930056687 hasConcept C2778690821 @default.

• next